Recent Transactions

20-Sep-21
Undisclosed
Spain flag
Target: 

Faes Farma, flagship product Bilastine

United States flag
Acquiror: 
Hikma Specialty USA INC

Advised Faes Farma in the signing of a long-term license agreement for its flagship product Bilastine with Hikma Specialty USA INC, a subsidiary of Hikma Pharmaceuticals PLC, for the United States of America

01-Jul-21
Undisclosed
Spain flag
Target: 

The Natural Fruit Company

Spain flag
Acquiror: 
Fremman Capital

Advised Fremman on the acquisition of The Natural Fruit Company, a leading European producer and distributor of citrus fruits (both conventional and organic) including oranges, lemons, tangerines, grapefruit and persimmon fruit

30-Jun-21
Pending
Undisclosed
Spain flag
Target: 

Deltalab

Thailand flag
Acquiror: 
SCG Packaging Public Company Limited

Advising Deltalab, a leading Spanish laboratory solutions provider with dedicated manufacturing capacity, on the sale of the company to SCG Packaging Public Company Limited, the largest integrated packaging and paper company in Southeast Asia

28-Jun-21
Pending
Undisclosed
Target: 

Portfolio of 16 European Consumer Healthcare brands from Sanofi

Germany flag
Acquiror: 
STADA Arzneimittel AG

Advising Sanofi, a leading global player in the Consumer Healthcare market, on the divestiture of a portfolio of 16 European Consumer Healthcare brands to STADA, a German pharmaceutical and consumer healthcare company owned by Bain Capital and Cinven

11-Jun-21
$248 million
United States flag
Target: 

My Alarm Center

United States flag
Acquiror: 
Ad Hoc Group of First Lien Lenders

Advised the Ad Hoc Group of First Lien Lenders on the pre-packaged Chapter 11 restructuring of My Alarm Center, a provider of security and smart home monitoring services

07-Jun-21
Undisclosed
Target: 

Rights to General, Right Guard and Dry Idea brands

flag not available
Acquiror: 
N/A

Advised Henkel on its brand divestment program (including the sale of the General, Right Guard and Dry Idea brands)

01-Jun-21
Undisclosed
United States flag
Target: 

VEP Healthcare

United States flag
Acquiror: 
U.S. Acute Care Solutions

Advised VEP Healthcare, a leading, physician-owned provider of clinical management services in emergent and inpatient settings in the United States, on its merger with U.S. Acute Care Solutions

10-May-21
Pending
N/A
Target: 

International Flavors & Fragrances, Inc.’s Fruit Preparations business

Acquiror: 
Frulact Serviços Partilhados, SA

Advised International Flavors & Fragrances on the divestiture of its European-based Fruit Preparation business to Frulact Serviços Partilhados, SA

07-May-21
N/A
United States flag
Target: 

MindPath Care Centers

United States flag
Acquiror: 
Community Psychiatry

Advised Community Psychiatry, a leading provider of outpatient behavioral health services with a focus on high-quality clinically-driven care, on its acquisition of MindPath Care Centers, deepening its national presence to more than 350 providers across the US

31-Mar-21
$801 million
United States flag
Target: 

Assets of NPC International, a former national Wendy’s and Pizza Hut franchisee

United States flag
Acquiror: 
Flynn Restaurant Group and a consortium of existing Wendy’s franchisees

Advised the Company on its chapter 11 proceedings and $801mm sale through a § 363 process

18-Mar-21
$750 million
Canada flag
Target: 

Canopy Growth Corporation

United States flag
Acquiror: 
King Street Capital Management, L.P.

Advised Canopy Growth, a leading diversified cannabis company, on its US$750 million term loan financing with King Street Capital Management, L.P.

26-Feb-21
$2.0 billion
United States flag
Target: 

MDLIVE

United States flag
Acquiror: 
Cigna

Advising Cigna on the acquisition of MDLIVE, a virtual care delivery platform, by Evernorth, Cigna’s health services portfolio

25-Feb-21
$1.5 billion
United States flag
Target: 

Ascena Retail Group, Inc.

United States flag
Acquiror: 
Sycamore Partners

Advised the Ad Hoc Group of First-Lien Term Loan lenders of Ascena Retail Group, Inc. with respect to (i) negotiation of a restructuring support agreement, including a fully backstopped DIP and exit financing and (ii) a sale of Ann Taylor, LOFT and Lane Bryant as well as the intellectual property assets of the Justice and Catherine’s brands.

19-Feb-21
$33 million
U.S.A., U.K. flags
Target: 

Acacia Pharma Group plc

flag not available
Acquiror: 
N/A

Advised Acacia Pharma Group plc, a US headquartered commercial stage biopharmaceutical company incorporated in England and listed in Belgium, on its placing of 10m new ordinary shares at a price of €2.70 per share

09-Feb-21
Undisclosed
United States flag
Target: 

US Acute Care Solutions

United States flag
Acquiror: 
Apollo Hybrid Value Fund

Advising US Acute Care Solutions, the largest majority physician-owned emergency medicine practice in the United States, on its recapitalization and buyout of minority partner, Welsh Carson

29-Dec-20
$110 million
United States flag
Target: 

Biogix, Inc.

United Kingdom flag
Acquiror: 
Alliance Pharma plc

Advised Biogix, Inc., a leader in the development, research and distribution of clinically tested menopause and perimenopause supplements in the U.S. under the flagship brand Amberen, on its sale to Alliance Pharma plc

13-Nov-20
$495 million
United States flag
Target: 

Libbey, Inc.

flag not available
Acquiror: 
N/A

Advised the Committee of Unsecured Creditors on the in-court restructuring of Libbey, Inc., a leading tableware manufacturer

13-Nov-20
$343 million
United States flag
Target: 

Revlon Consumer Products Corporation

flag not available
Acquiror: 
N/A

Advised Ad Hoc Group of Note Holders with respect to Revlon’s Exchange Offer

16-Oct-20
$430 million
United States flag
Target: 

Alert 360 (Central Security Group, Inc.)

flag not available
Acquiror: 
N/A

Advised the Ad Hoc Group of First Lien Lenders on the out-of-court restructuring of Alert 360 (Central Security Group, Inc.), a leading home-security provider

04-Oct-20
Undisclosed
France flag
Target: 

Cosmetic applications endolysin

Netherlands flag
Acquiror: 
L’Oréal

Advised Micreos, a fast-growing biotechnology company, on a long-term license agreement with L’Oréal for one of Micreos’ phage-based active ingredients, SA.100

01-Oct-20
$1.05 billion
United States flag
Target: 

Akorn, Inc.

flag not available
Acquiror: 
First Lien Term Loan Lenders

Advised Ad Hoc Group of First Lien Term Loan Lenders on Akorn’s in-court recapitalization

30-Sep-20
$236 million
United States flag
Target: 

J. Jill, Inc.

United States flag
Acquiror: 
TowerBrook Capital Partners L.P.

Advised TowerBrook Capital Partners L.P., a leading investment management company and majority shareholder of J. Jill, on the comprehensive out-of-court recapitalization of J. Jill 

15-Sep-20
$NA
United States flag
Target: 

Surgery Partners’ Anesthesia Services

United States flag
Acquiror: 
NorthStar Anesthesia

Advised Surgery Partners, a leading owner and operator of surgical facilities, on the divestiture of its anesthesia services business to NorthStar Anesthesia   

12-Aug-20
$225 million
United States flag
Target: 

340B Link

United States flag
Acquiror: 
Omnicell

Advising Omnicell, a leading provider of medication management solutions and adherence tools for health systems and pharmacies, on the acquisition of the 340B Link business from Pharmaceutical Strategies Group (PSG)

29-Jul-20
$NA
Spain flag
Target: 

Integrated supplier of preserved and frozen vegetables

Spain flag
Acquiror: 
ACON Agri Investments S.L.

Advised ACON Agri Investments S.L., a special purpose vehicle of ACON Investments LLC, on the acquisition of Grupo Alsur, a leading integrated supplier of preserved and frozen vegetables with operations in Spain and Peru

Pages

show all